Lexology May 4, 2022
The Centers for Medicare & Medicaid Services (CMS) released its Final Rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (Final Rule) late last week. We summarized the major provisions of the CY 2023 Proposed Rule in a blog series in January, noting that the proposals sought to increase consumer protections and reduce health disparities, with a strong emphasis on policies impacting individuals who are dually eligible for Medicare and Medicaid.
This is the first post in our series on the Final Rule. Here, we discuss one of the more controversial provisions that CMS finalized and which will have immediate impacts on almost all Medicare Advantage (MA) plans: policy changes...